2009

Savannah, Georgia– April 27-30, 2009
Louisville, Kentucky – May 12-15, 2009

The Drug Enforcement Administration’s Office of Diversion Control is currently planning four, two-day Pharmaceutical Training Seminars (Seminars). The first two Seminars will be hosted in Savannah, Georgia from April 27 - 30, 2009 at the Hyatt Regency Savannah, located at Two W Bay St., Savannah, Georgia 31401. The DEA has secured a group rate for this location at $199.00 (per night) plus applicable taxes and fees. After you have received confirmation from DEA regarding your attendance, please call for reservations no later than March 26, 2009 at (800)-233-1234. In order to secure this room rate, reference the "DEA Pharmaceutical Training Seminar room block" when making your reservation.

Taxi service (one way) from the airport to the hotel is approximately $25.00. For additional information visit the following weblink: http://www.savannahairport.com/groundtransport.php.

The second two Seminars will be hosted in Louisville, Kentucky from May 12 - 15, 2009 at the Marriott Louisville Downtown, located at 280 W. Jefferson St., Louisville, Kentucky 40202. The DEA has secured a group rate for this location at $167.00 (per night) plus applicable taxes and fees. After you have received confirmation from DEA regarding your attendance, please call for reservations not later than April 13, 2009 at (800)-533-0127. In order to secure this room rate, reference the "DEA Pharmaceutical Training Seminar" when making your reservation.

Local shuttle service is available to and from the airport for approximately $10.00 each way.

The four seminars (identical in content), will cover quotas, year-end reporting, ARCOS reporting, import/export permits and declarations, scheduled investigations and the Combat Methamphetamine Epidemic Act. Please note that the Savannah seminars will emphasize schedule I and II controlled substance quotas, while the Louisville seminars will emphasize list I quotas. DEA will also include content regarding the registration process for manufacturers and importers of Schedule I and II controlled substances. Please review the tentative agenda for additional details.

There is no registration cost for the Seminar. Attendees will be required to pay for both their travel to the Seminar and their accommodations in either Savannah or Louisville. You are not required to stay at the hotels listed above however DEA will be unable to assist in finding an alternative location.

To register for the 2009 Pharmaceutical Training Seminars, DEA registered manufacturers, importers and exporters are invited to complete the registration application. Applications should be submitted (via fax) to:

Office of Diversion Control
Attn: ODE
Fax #: 202-353-1263

Please note that all registration forms will be handled on a first come, first serve basis and that registration is limited to 2 employees per registration. Please be advised that a certain number of seats will be reserved for applicants that have not previously attended. Confirmation will be sent via email or fax. We hope to see you there!!

2009 DEA Pharmaceutical Training Seminars

Savannah, Georgia– April 27- 30, 2009
Louisville, Kentucky – May 12-15, 2009

Tentative Agenda *

Day 1

• 8:00 – 8:30 Registration
• 8:30 – 9:00 Welcoming Remarks and Introduction to the Seminars
• 9:00 – 9:45 Registration of Manufacturers and Importers (Section 303 Investigations)
• 9:45 – 10:00 Break
• 10:00 – 11:30 Inventories, Records, and Reports
• 11:30 – 1:00 Lunch
• 1:00 – 1:45 Quotas
• 1:45 – 2:15 Research vs. Manufacturing
• 2:15 – 3:00 Quota Applications
• 3:00 – 3:15 Break
• 3:15 – 4:00 Quota Applications (con’t.)

Day 2

• 8:30 – 9:30 Import/Export
• 9:30 – 9:45 Break
• 9:45 – 10:45 Import/Export (con’t.)
• 10:45 – 11:45 Diversion Investigator
• 11:45 – 1:00 Lunch
• 1:00 – 2:30 Year-End Report Generator
• 2:30 – 2:45 Break
• 2:45 – 4:45 ARCOS

2009 DEA Pharmaceutical Training Seminars

Savannah, Georgia– April 27- 30, 2009
Louisville, Kentucky – May 12-15, 2009

Introduction to the Pharmaceutical Training Seminars

• What is the Single Convention and the Psychotropic Convention
• Domestic Legislation in Relation to International Treaties
• Overview of Industry Responsibilities with Regard to International Treaties and Domestic Legislation
• DEA’s utilization of information gathered from registrants for purposes of its reporting responsibilities to the United Nations

Registration of Manufacturers and Importers of Schedule Is and IIs

• What is a "303-investigation" and why is it performed
• How does DEA utilize additional questions in evaluating a manufacturer or import registration application

Inventories, Records, and Reports

• Role of the Diversion Control Program
• Registrant inventories, records and report requirements
• How industry can assist DEA to prevent diversion

Quotas

• Legislative History
• Combat Methamphetamine Epidemic Act
• Types and Purpose of Quotas
• Information and Procedure Used to Establish Quotas

Research vs. Manufacturing

• Registration Coincident Activities
• Research vs. Manufacturing Activities
• Historical Determinations

Quota Applications

• Explanation of Quota Applications
• Quotas Adjustments
• Authorized Destructions
• Exercises

Import/Export

• Legislation and General Information
• Explanation of the DEA-161, DEA-357 and DEA-236
• Transshipments
• Filing of Return Information

Diversion Investigator

• How DEA Approaches and Completes a Registrant Inspection

Year-End Report Generator

• Explanation of Year-end Reports
• YERs On line
• Common Problems Encountered

ARCOS

• What and How Manufacturers Report to ARCOS
• An Explanation of the ARCOS Manufacturing Codes
• Current Reporting Method and Future Reporting Requirements
• An Explanation of the ARCOS Edit Error Codes and How to Correct ARCOS Reports
• Proposed Elimination of Manufacturing Codes from the ARCOS System